Caseware UK (AP4) 2024.0.164 2024.0.164 2024-08-312024-08-31falsetrue46false2023-09-01No description of principal activity51false 02396001 2023-09-01 2024-08-31 02396001 2022-09-01 2023-08-31 02396001 2024-08-31 02396001 2023-08-31 02396001 c:Director1 2023-09-01 2024-08-31 02396001 d:Buildings 2023-09-01 2024-08-31 02396001 d:Buildings 2024-08-31 02396001 d:Buildings 2023-08-31 02396001 d:Buildings d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2023-09-01 2024-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2024-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2023-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2023-09-01 2024-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2024-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2023-08-31 02396001 d:LandBuildings 2024-08-31 02396001 d:LandBuildings 2023-08-31 02396001 d:PlantMachinery 2023-09-01 2024-08-31 02396001 d:PlantMachinery 2024-08-31 02396001 d:PlantMachinery 2023-08-31 02396001 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 02396001 d:FurnitureFittings 2023-09-01 2024-08-31 02396001 d:FurnitureFittings 2024-08-31 02396001 d:FurnitureFittings 2023-08-31 02396001 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 02396001 d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 02396001 d:CurrentFinancialInstruments 2024-08-31 02396001 d:CurrentFinancialInstruments 2023-08-31 02396001 d:Non-currentFinancialInstruments 2024-08-31 02396001 d:Non-currentFinancialInstruments 2023-08-31 02396001 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 02396001 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 02396001 d:Non-currentFinancialInstruments d:AfterOneYear 2024-08-31 02396001 d:Non-currentFinancialInstruments d:AfterOneYear 2023-08-31 02396001 d:ShareCapital 2024-08-31 02396001 d:ShareCapital 2023-08-31 02396001 d:RetainedEarningsAccumulatedLosses 2024-08-31 02396001 d:RetainedEarningsAccumulatedLosses 2023-08-31 02396001 d:AcceleratedTaxDepreciationDeferredTax 2024-08-31 02396001 d:AcceleratedTaxDepreciationDeferredTax 2023-08-31 02396001 d:OtherDeferredTax 2024-08-31 02396001 d:OtherDeferredTax 2023-08-31 02396001 c:OrdinaryShareClass1 2023-09-01 2024-08-31 02396001 c:OrdinaryShareClass1 2024-08-31 02396001 c:OrdinaryShareClass1 2023-08-31 02396001 c:FRS102 2023-09-01 2024-08-31 02396001 c:Audited 2023-09-01 2024-08-31 02396001 c:FullAccounts 2023-09-01 2024-08-31 02396001 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 02396001 c:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 02396001 2 2023-09-01 2024-08-31 02396001 7 2023-09-01 2024-08-31 02396001 e:PoundSterling 2023-09-01 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 02396001










JAPAN GREEN MEDICAL CENTRE LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
JAPAN GREEN MEDICAL CENTRE LIMITED
REGISTERED NUMBER: 02396001

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
439,932
451,312

  
439,932
451,312

Current assets
  

Stocks
 5 
32,107
34,669

Debtors: amounts falling due after more than one year
 6 
94,787
94,787

Debtors: amounts falling due within one year
 6 
984,299
844,973

Cash at bank and in hand
 7 
1,044,762
1,332,127

  
2,155,955
2,306,556

Creditors: amounts falling due within one year
 8 
(403,279)
(346,849)

Net current assets
  
 
 
1,752,676
 
 
1,959,707

Total assets less current liabilities
  
2,192,608
2,411,019

Creditors: amounts falling due after more than one year
 9 
-
(600,000)

Provisions for liabilities
  

Deferred tax
 10 
(33,577)
(42,411)

  
 
 
(33,577)
 
 
(42,411)

Net assets
  
2,159,031
1,768,608


Capital and reserves
  

Called up share capital 
 11 
2,000,000
2,000,000

Profit and loss account
  
159,031
(231,392)

  
2,159,031
1,768,608

Page 1

 
JAPAN GREEN MEDICAL CENTRE LIMITED
REGISTERED NUMBER: 02396001
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2024

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 November 2024.




Dr Y Takaya
Director

The notes on pages 3 to 12 form part of these financial statements.

Page 2

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1.


General information

Japan Green Medical Centre Limited is a private company limited by shares, registered in England. The address of registered office is Basement, 10 Throgmorton Avenue, London, EC2N 2DL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.7

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 4

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)


2.10
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
Building element over 30 years
Long-term leasehold property
-
20%
Short-term leasehold property
-
20%
Plant and machinery
-
20%
Fixtures and fittings
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.15

Holiday pay accrual

A liability is recognised to the extent of any unused holiday pay entitlement which is accrued at the balance sheet date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the balance sheet date.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Average number of employees
51
46

Page 7

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

4.


Tangible fixed assets





Freehold property
Long-term leasehold property
Short-term leasehold property
Plant and machinery
Fixtures and fittings

£
£
£
£
£



Cost or valuation


At 1 September 2023
306,005
417,703
122,968
373,837
267,678


Additions
-
-
-
4,605
26,539



At 31 August 2024

306,005
417,703
122,968
378,442
294,217



Depreciation


At 1 September 2023
72,882
417,703
122,968
244,184
179,142


Charge for the year on owned assets
4,239
-
-
9,382
28,903



At 31 August 2024

77,121
417,703
122,968
253,566
208,045



Net book value



At 31 August 2024
228,884
-
-
124,876
86,172



At 31 August 2023
233,123
-
-
129,653
88,536
Page 8

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

           4.Tangible fixed assets (continued)


Total

£



Cost or valuation


At 1 September 2023
1,488,191


Additions
31,144



At 31 August 2024

1,519,335



Depreciation


At 1 September 2023
1,036,879


Charge for the year on owned assets
42,524



At 31 August 2024

1,079,403



Net book value



At 31 August 2024
439,932



At 31 August 2023
451,312




The net book value of land and buildings may be further analysed as follows:


2024
2023
£
£

Freehold
228,884
233,123

228,884
233,123



5.


Stocks

2024
2023
£
£

Finished goods and goods for resale
32,107
34,669

32,107
34,669


Page 9

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

6.


Debtors

2024
2023
£
£

Due after more than one year

Other debtors
94,787
94,787

94,787
94,787


2024
2023
£
£

Due within one year

Trade debtors
647,145
538,880

Other debtors
26,395
24,810

Prepayments and accrued income
310,759
281,283

984,299
844,973



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
1,044,762
1,332,127

1,044,762
1,332,127


The Bankers of the Company have a legal charge over the deposits and the Freehold Property of the Company.


8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
134,487
89,135

Corporation tax
139,195
125,305

Other taxation and social security
60,395
52,919

Other creditors
5,492
7,278

Accruals and deferred income
63,710
72,212

403,279
346,849


Page 10

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

9.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Loan from parent undertaking
-
600,000

-
600,000


The loan was an intercompany loan at an interest of 2.1% (reviewed annually) and payable by 31 March 2025. However, an early repayment of the  full balance has been made in August 2024.


10.


Deferred taxation




2024


£






At beginning of year
(42,411)


Charged to profit or loss
8,834



At end of year
(33,577)

The deferred tax asset is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(42,411)
(42,411)

Charged to profit or Loss
8,834
-

(33,577)
(42,411)


11.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



2,000,000 (2023 - 2,000,000) Ordinary shares of £1.00 each
2,000,000
2,000,000


Page 11

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

12.


Capital commitments


At 31 August 2024 the Company had capital commitments as follows:

2024
2023
£
£


X-ray machine - contracted for but not provided in these financial statements
283,916
283,916

283,916
283,916


13.


Pension commitments

The Company operates a defined contributions pension sheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. There is no contributions payable to the fund at the balance sheet date.


14.


Other financial commitments

As at the balance sheet date, the Company had other financial commitments with a supplier  as follows:


2024
2023
£
£



Not later than 1 year
23,291
23,291

Later than 1 year and not later than 5 years
46,582
69,872

69,873
93,163




15.


Controlling party

The immediate and ultimate parent undertaking is JGH. Holdings Pte Ltd registered in Singapore. 
 
The smallest and largest group of which the Company is a member of and which prepares consolidated accounts is JGH Holdings Pte Ltd. The address of registered office of JGH. Holdings Pte Ltd is 290 Orchard Road, #10-01 Paragon, Singapore 238859


16.


Auditors' information

The auditors' report on the financial statements for the year ended 31 August 2024 was unqualified.

The audit report was signed on 29 November 2024 by Yusuke Takanishi (Senior Statutory Auditor) on behalf of Greenback Alan LLP.

Page 12